Form Type: 4

SEC EDGAR Link
Accession Number:0001127602-21-016099
Date:2021-05-07
Issuer: CVS HEALTH CORP (CVS)
Original Submission Date:

Reporting Person:

BRENNAN TROYEN A
ONE CVS DRIVE
WOONSOCKET, RI 02895

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2021-05-07 S 9,477 d $84.00 144,697 direct
COMMON STOCK (RESTRICTED) 0 $0.00 4,805 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION 102.26 deemed execution date 0 ( ) 2016-04-01 2022-04-01 common stock 47,937 $102.26 47,937 direct
STOCK OPTION 104.82 deemed execution date 0 ( ) 2017-04-01 2023-04-01 common stock 53,772 $104.82 53,772 direct
STOCK OPTION 78.05 deemed execution date 0 ( ) 2018-04-03 2024-04-03 common stock 75,134 $78.05 75,134 direct
STOCK OPTION 62.21 deemed execution date 0 ( ) 2019-04-01 2025-04-01 common stock 87,575 $62.21 87,575 direct
STOCK OPTION 54.19 deemed execution date 0 ( ) 2020-04-01 2029-04-01 common stock 161,605 $54.19 161,605 direct
STOCK OPTION 58.34 deemed execution date 0 ( ) 2021-04-01 2030-04-01 common stock 112,637 $58.34 112,637 direct
STOCK OPTION 74.3 deemed execution date 0 ( ) 2022-04-01 2031-04-01 common stock 99,344 $74.30 99,344 direct
Footnotes
IDfootnote
f1 all sales were effected pursuant to a rule 10b5-1 plan.
f2 option became exercisable in four equal annual installments, commencing 4/1/2016.
f3 option became exercisable in four equal annual installments, commencing 4/1/2017.
f4 option became exercisable in four equal annual installments, commencing 4/3/2018.
f5 option became exercisable in four equal annual installments, commencing 4/1/2019.
f6 option became exercisable in four equal annual installments, commencing 4/1/2020.
f7 the number of shares subject to the option were calculated using a 30-day average price.
f8 options became exercisable in four equal annual installments, commencing 4/1/2021.
f9 option becomes exercisable in four equal annual installments, commencing 4/1/2022.

Elevate your investments